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Abstract
Background: PCR amplification for the detection of pathogens in biological material is generally considered a rapid 
and informative diagnostic technique. Invasive Salmonella serovars, which cause enteric fever, can be commonly 
cultured from the blood of infected patients. Yet, the isolation of invasive Salmonella serovars from blood is protracted 
and potentially insensitive.
Methods: We developed and optimised a novel multiplex three colour real-time PCR assay to detect specific target 
sequences in the genomes of Salmonella serovars Typhi and Paratyphi A. We performed the assay on DNA extracted 
from blood and bone marrow samples from culture positive and negative enteric fever patients.
Results: The assay was validated and demonstrated a high level of specificity and reproducibility under experimental 
conditions. All bone marrow samples tested positive for Salmonella, however, the sensitivity on blood samples was 
limited. The assay demonstrated an overall specificity of 100% (75/75) and sensitivity of 53.9% (69/128) on all biological 
samples. We then tested the PCR detection limit by performing bacterial counts after inoculation into blood culture 
bottles.
Conclusions: Our findings corroborate previous clinical findings, whereby the bacterial load of S. Typhi in peripheral 
blood is low, often below detection by culture and, consequently, below detection by PCR. Whilst the assay may be 
utilised for environmental sampling or on differing biological samples, our data suggest that PCR performed directly on 
blood samples may be an unsuitable methodology and a potentially unachievable target for the routine diagnosis of 
enteric fever.
Background
The detection of invasive Salmonella  serovars such as
Salmonella Typhi (S. Typhi) and Salmonella Paratyphi A
(S. Paratyphi A) remains a challenging problem. Depend-
ing on the location, various different tests and clinical cri-
teria are used to distinguish febrile disease of differing
aetiology, many of which still may remain unsatisfactorily
identified. In resource poor settings with a high disease
burden, enteric fever is largely distinguished on the basis
of clinical symptoms and syndromes [1-4]. Yet, clinical
symptoms are not the most reliable assessment for
enteric fever, as other conditions, such as typhus, malaria
and leptospirosis have similar clinical manifestations and
are also common in places such as Nepal [5,6].
The current WHO guidelines for typhoid fever states
that "The definitive diagnosis of typhoid fever depends on
the isolation of S. Typhi from blood, bone marrow or a
specific anatomical lesion" and concludes "Blood culture
is the mainstay of the diagnosis of this disease" [7]. How-
ever, in practice, neither blood or bone marrow culture is
performed routinely. Many hospitals in resource limited
settings do not have adequate microbiological laboratory
facilities and personnel to perform such a technique. Our
current unpublished data suggests that only 40% of
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patients with a clinical syndrome indicative of enteric
fever attending Patan Hospital in Kathmandu are culture
positive for invasive Salmonellae. The culturing of bone
marrow biopsies from enteric fever patients has a higher
sensitivity than blood culture (between 70% and 80% on
clinically diagnosed cases [8,9]) but is seldom performed
due to the aggressive nature of the investigation. Cultur-
ing biological specimens from patients can also not be
considered rapid; it may take between one and three days
for positive blood culture and a further one to two days
for identification and antimicrobial resistance profiling.
We aimed to develop, initially for research purposes, a
robust and rapid test for the identification of S. Typhi and
S. Paratyphi A in biological specimens, with the possibil-
ity that it may form the basis of a suitable diagnostic test
in the future. PCR offers a potentially attractive method-
ology for the detection of invasive Salmonella serovars.
PCR amplification is commonly used in many clinical
research laboratories for the detection of multiple patho-
gens. Furthermore, there are several publications demon-
strating the utility of PCR for the detection of invasive
Salmonella serovars in the blood [10-14]. Yet, the use of
PCR for the definitive diagnosis of enteric fever is some-
what contentious, despite the method being previously
referred to as "the gold standard for diagnosis" [15]. Our
understanding is that PCR is not routinely performed in
areas with endemic enteric fever and the invalidated
methodology means PCR should be not considered a reli-
able method for diagnosis or for measuring disease bur-
den.
Here we address some of the issues with the use of PCR
for detection of invasive Salmonella serovars, and con-
sider if this methodology could evolve into a standardised
test that may be used as a complementary diagnostic tool
in the future. Therefore, we developed a novel multiplex
real-time PCR assay that would amplify specific DNA
sequences from S. Typhi and S. Paratyphi A. We then
tested the methodology on biological samples collected
from enteric fever patients.
Methods
Patient selection, blood and bone marrow sampling
Blood samples were collected from patients presenting to
Patan Hospital, Kathmandu, Nepal with suspected
uncomplicated enteric fever that had not taken antimi-
crobials prior to admission. Bone marrow specimens
w e r e  t a k e n  f r o m  pa t i e n ts  a d m i t t ed  t o  t h e  H os p i t a l  f o r
tropical diseases in Ho Chi Minh City, Vietnam with sus-
pected enteric fever. The study was approved by the sci-
entific committees and ethical committees of the
participating institutions. Written informed consent was
obtained from all participants or guardians of partici-
pants. Samples of 10 ml of anti-coagulant blood were col-
lected in EDTA tubes from febrile patients over the age of
12 years old; 6 ml was used for the isolation of Salmonella
serovars by routine blood culture. The remaining 4 ml
was centrifuged at 1,100 RCF for 10 minutes and the
plasma and whole blood cell pellets were separated and
stored at -80°C. Bone marrow biopsies were taken as pre-
viously described [16], bone marrow was cultured for the
isolation of Salmonella serovars and 1 ml of tissue was
stored at -80°C until DNA extraction.
Target sequence selection
Sequences unique to S.  Typhi or S.  Paratyphi A were
identified using a whole-genome comparison of S. Typhi
strain CT18 (GenBank AL513382) [17] and S. Paratyphi
A strain AKU12601 (GenBank FM200053) [18], con-
ducted using BLASTn and visualized using the Artemis
Comparison Tool (ACT). To confirm whether these
sequences were likely to discriminate more generally
between members of the S. Typhi and S. Paratyphi A pop-
ulations, we searched for sequences in all available S.
Typhi (finished sequence for strain Ty2 (GenBank
AE014613) and 17 additional 454 shotgun-sequenced
strains (GenBank CAAV01000001-CAAV01003682)) [19]
and S. Paratyphi A strains (finished sequence for strain
ATCC9150 (GenBank CP000026)). Genomic data from
the recent S. Typhi and S. Paratyphi A sequencing proj-
ects were mined to find genes that were specific for each
serovar [18,19]. The criteria for selection were; a lack of
homology with other genes in other pathogens or human
sequences (to ensure no cross-reactivity) and the
sequence was required to be conserved in all the re-
sequenced and previously sequenced strains.
DNA manipulation, bacterial strains and construction of 
internal control
All bacterial strains used in this study are presented in
Table 1. Strain E. coli VU1 was constructed by PCR
amplifying the gB gene from Phocid herpes virus using
the primers phHV-1 forward and reverse [20]. The gB
gene amplicon was cloned into plasmid pCR 2.1-TOPO
(Invitrogen). E. coli VU1 was to act as an internal control
to monitor DNA extraction and amplification efficiency
in all PCR reactions using primers phHV-1 forward and
reverse and a specific probe [20]. PCR amplicons for all
target sequences were produced by monoplex conven-
tional PCR using the primer sequences outlined below. E.
coli  TOP10 cells (Invitrogen) were transformed with
purified plasmid DNA containing target DNA sequence
and PCR amplicons were sequenced (Applied Biosys-
tems) to ensure accurate amplification. Purified plasmid
DNA was used as template in all subsequent experiments
which utilized a standard curve.
Total genomic and plasmid DNA extraction
Volumes of 200 μl to 2 ml of experimental blood samples
(for laboratory assessment) were used for total DNANga et al. BMC Infectious Diseases 2010, 10:125
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extraction. From patient samples, we consistently used 2
ml of blood cell pellets and 1 ml of bone marrow biopsies
spiked with 50 μl of E. coli VU1 for total DNA isolation.
Extractions were performed under sterile conditions
using the QIAamp DNA Blood Midi Kit (Qiagen) accord-
ing to the manufacturer's recommendations. DNA was
re-suspended in 300 μl of elution buffer, stored at 4°C and
subjected to PCR within 24 hours of preparation. Plasmid
DNA was purified from E. coli VU1 and from strains con-
taining PCR target DNA using the QIAprep Spin Mini-
prep (Qiagen) according to the manufacturer's
recommendations. In total, the PCR assay was performed
on blood samples from 100 patients with blood culture
confirmed enteric fever, 50 blood samples from patients
with presumptive enteric fever (blood culture negative),
25 patients with bacteraemia caused by organisms other
than S. Typhi or S. Paratyphi A and 28 bone marrow biop-
sies from patients with culture confirmed enteric fever
cause by S. Typhi.
Primers and PCR conditions
Primers and probes specific A were designed using
Primer Express Software (Applied biosystems) and man-
ufactured by Sigma -Proligo (Singapore). Primers and
probes sequences were as follows; S.  Typhi; ST-Frt 5'
CGCGAAGTCAGAGTCGACATAG 3', ST-Rrt 5'
AAGACCTCAACGCCGATCAC 3', ST- Probe 5' FAM-
CATTTGTTCTGGAGCAGGCTGACGG-TAMRA 3'; S.
Paratyphi A; Pa-Frt 5'ACGATGATGACTGATTTATC-
GAAC 3', Pa-Rrt 5' TGAAAAGATATCTCTCA-
GAGCTGG 3', Pa-Probe 5' Cy5-CCCATACAATTTCAT
TCTTATTGAGAATGCGC-BHQ5 3' and Phocid herpes
virus; PhHV-Frt 5' GGGCGAATCACAGATTGAATC 3',
PhHV-Frt 5' GCGGTTCCAAACGTACCAA 3', phHV-
Probe-hex 5' Hex-TTTTTATGTGTCCGCCACCATCT-
GGATC-TAMRA 3'.
PCR reactions were performed in 25 μl reaction vol-
umes consisting of 5 mM MgCl2, 0.2 mM each deoxynu-
cleotide triphosphate, 1 U of Hot start Taq DNA
po l ym e r as e  ( Q i a g e n )  a n d  5  μ l  o f  t e m p l a t e  D N A.  F i n a l
reaction concentrations of the three primer and probe
sets for internal control, S. Typhi and S. Paratyphi A were
0.4 μM of each primer and 0.15 μM of each probe. PCR
was performed on a Bio-Rad Chromo 4 real-time PCR
system and fluorescence was released via the TaqMan 5'
to 3' exonuclease activity. All PCRs were cycled under the
following conditions; 15 min at 95°C and 45 cycles of 30
sec at 95°C, 30 sec at 60°C and 30 sec at 72°C.
Real-time PCR, quantification, reproducibility and 
interpretation
Plasmid DNA with cloned target DNA sequences (S.
Typhi and S. Paratyphi A) were purified and concentra-
tions (μg/ml) were calculated by a NanoDrop spectro-
Table 1: Bacterial strains used in this study
Strains Number Description/Source
Laboratory isolates
Salmonella Typhi CT18 - Sanger Institute collection
Salmonella Paratyphi A AKU12601 - Sanger Institute collection
E. coli Vu 1 - Cloned gB target sequence - this study
E. coli Vu 2 - Cloned STY0201 target sequence - this study
E. coli Vu 3 - Cloned SSPA2308 target sequence - this study
Clinical isolates
Salmonella Typhi 80 OUCRU Nepal
Salmonella Paratyphi A 60 OUCRU Nepal
Staphylococcus. spp 3O U C R U  V i e t n a m
Streptococcus pneumoniae 1O U C R U  V i e t n a m
Streptococcus suis type 2 2 OUCRU Vietnam
Streptococcus group B 1 OUCRU Vietnam
Neisseria meningitidis 1O U C R U  V i e t n a m
Citrobacter freundii 4O U C R U  V i e t n a m
Klebsiella pneumoniae 1O U C R U  V i e t n a m
Salmonella serotypes 10 OUCRU VietnamNga et al. BMC Infectious Diseases 2010, 10:125
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photometer (Thermo-Scientific). Concentrations were
converted to copy number using the formula; mol/g ×
molecules/mol = molecules/g, via a DNA copy number
calculator http://www.uri.edu/research/gsc/resources/
cndna.html. Plasmid solutions were diluted in 10-fold
serial dilutions ranging from 100 to 105 plasmid copies per
μl. Serially diluted plasmid DNA was mixed in increasing
(S. Typhi target) and decreasing (S. Paratyphi A target)
concentrations and subjected to real-time PCR amplifica-
tion. Standard curves for S. Typhi and S. Paratyphi A copy
number were constructed by plotting the Ct value against
the plasmid DNA copy number. The intra-assay co-effi-
cient of variance was calculated by the assessing deviation
in Ct values of a selected plasmid concentration. This was
performed using four replicates all of which were ampli-
fied on the same day. Inter-assay variation was calculated
by measuring the variation in Ct values of selected con-
centrations over a four day period. Accurate DNA extrac-
tion and amplification was confirmed in all experiments
by production of a green signal from the internal control.
A negative PCR result was concluded if negative controls
were negative, the internal control showed an expected
Ct value and the reporter signal for S. Typhi or S. Para-
typhi A could not be detected. Data was deemed none-
interpretable when the negative control demonstrated
contamination and/or the internal control did not yield a
sufficient  Ct value. For each run of the real-time PCR
assay, DNA from S.  Typhi CT18 and S.  Paratyphi A
AKU12601 was included as a positive control in the assay
plate. All statistical analyses were performed in R http://
www.r-project.org/.
Laboratory assay for detection limits
The experimental detection limit was calculated using
two methodologies and subsequent results were com-
pared to assess variability. Initially, 10 ml cultures of S.
Typhi and S. Paratyphi A were grown overnight with aer-
ation at 37°C in Luria-Bertani media and 200 μl was used
to inoculate one ml of whole blood. Serial dilutions of the
inoculated blood samples were made and the bacterial
suspensions were concurrently serially diluted in phos-
phate buffered saline. 200 μl of each dilution of saline and
the corresponding blood specimen was used for total
DNA extraction (as described above). DNA was re-sus-
pended in 200 μl of elution buffer. Bacterial counts for
each bacterial dilution in blood and saline were per-
formed in triplicate and enumerated on Luria-Bertani
media. The numbers of colony forming units were com-
pared to the Ct value following real-time PCR amplifica-
tion. Additionally, real-time PCR was performed on serial
dilutions of isolated plasmid DNA containing cloned tar-
get sequences until a positive signal could no longer be
detected from the assay.
Blood inoculation experiment
One ml of whole blood was inoculated with 200 μl of an
overnight culture of S. Typhi (as above) and was equili-
brated at 37°C with agitation for 16 hours. Serial dilutions
of the inoculated blood sample were performed concur-
rently in phosphate buffered saline and whole blood. The
resulting bacterial dilutions were enumerated on Luria-
Bertani media and total DNA was extracted from 200 μl
of diluted blood and PBS. Additionally, the remaining
diluted blood samples were inoculated into 25 ml
BACTEC Plus aerobic bottles (Becton - Dickinson) and
incubated at 37°C in a BACTEC 9050 machine (Becton
Dickinson) as per the manufacturers recommendations,
until growth was detected. Any cultured organisms were
sub-cultured to ensure no contamination. This experi-
ment was also performed on inoculated whole blood
individually treated with gentamycin and ciprofloxacin.
Blood was inoculated as before and either gentamycin or
ciprofloxacin (Sigma Aldrich) was added (to a final con-
centration of 100 μg/ml) and incubated at 37°C for two
hours.
Results
Optimisation of a three color multiplex real-time PCR assay
We were able to identify several potential DNA sequence
targets that were specific to S. Typhi or S. Paratyphi A and
demonstrated no DNA homology to other sequences
found in database searches. Ultimately, we selected an
individual coding sequence target from each of the two
serovars. These were; STY0201 from S. Typhi, (encoding
a putative fimbrial-like adhesin protein located at posi-
tion 210,264 in the S. Typhi CT18 chromosome genome
sequence (Accession number NC_003198)) and
SSPA2308 from S. Paratyphi A (encoding a hypothetical
protein at position 2,572,177 in the S.  Paratyphi A
AKU_12601 chromosome (Accession number
FM200053)).
The S. Typhi specific primers were predicted to pro-
duce a 131 bp amplicon from within gene STY0201 and
the S. Paratyphi A primers were predicted to amplify a
104 bp fragment within the gene SSPA2308. PCR reac-
tions were optimized and multiplexed. Strain E. coli
incorporating the VU1 phocid virus gene was added to
ensure accurate DNA extraction from all specimens and
to act as a positive control during amplification. An E. coli
or Salmonella gene target was deemed inappropriate due
to obvious cross hybridization problems.
The serovar specific loci were present in all available
genome sequences and we ensured the presence of the
target sequences on DNA extracted from 140 S. Typhi
and S. Paratyphi A strains by PCR (these strains included
the 100 strains isolated from blood specimens used in
later experiments). Prior to extraction, the bacterial cul-Nga et al. BMC Infectious Diseases 2010, 10:125
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tures were spiked with 200 μl of E. coli VU1. To control
for potential cross reactivity, 10 other Salmonella sero-
vars (including Enteritidis, Typhimurium and Paratyphi
C) and 13 other bacterial pathogens commonly isolated
during blood culture, including Staphylococcus aureus
and Streptococcus pneumoniae (T able 1) were tested for
the presence of the DNA sequences.
When the real-time PCR amplification was performed
on DNA prepared from either S. Typhi or S. Paratyphi A
the assay demonstrated serovar specific amplification on
all tested DNA samples. We could detect a positive inter-
nal control signal in all amplifications and were unable to
detect amplification of the S. Typhi and S. Paratyphi A
target sequences in DNA from other Salmonella serovars
or other bacterial pathogens (data not shown). Therefore,
on extracted DNA, the real-time PCR assay demon-
strated good specificity. The final assay conditions dem-
onstrated no cross-hybridization when performed
individually on DNA extracted from E. coli VU1, S. Typhi
or S. Paratyphi A (Table 2). The addition of the internal
control did not hinder detection of the target sequences
from either S. Typhi or S. Paratyphi A over a range of
DNA concentrations (Table 2).
Using serially diluted quantities of plasmid DNA con-
taining  S.  Typhi and S.  Paratyphi A (extracted from
strains VU2 and VU3) target sequences, we assessed the
detection limit, reproducibility and quantitative ability of
the assay. Table 2 shows the results of consecutive stan-
dard curve experiments and demonstrates the overall
performance, intra-assay variation and the inter-assay
variation. The inter-assay co-efficient of variance ranged
from 0.86 to 3.39% with copy number ranging from 5 ×
101 to 5 × 105 copies per reaction. Repeat standard curve
experiments were performed on DNA extracted from
PBS and whole blood spiked with S.  Typhi (Table 3).
There was an insignificant variation (p > 0.1 with none-
parametric student's t-test) in Ct  value when the PCR
assay was performed on DNA extracted from whole
blood or PBS inoculated with a known quantity of bacte-
rial cells. The detection limit of the assay ranged from
between 1 to 5 target copies per reaction. Therefore, in
spiked samples, the real-time PCR method, was specific,
sensitive and not influenced by potential inhibitors in
blood or by the addition of the E. coli internal control.
Performance of PCR assay on biological specimens
We performed the multiplex PCR assay on blood samples
taken from 100 culture confirmed enteric fever patients.
Fifty four of the 100 blood samples were culture positive
for S. Typhi and 46 blood samples were culture positive
for S. Paratyphi A. Both the S. Typhi and the S. Paratyphi
A clinical isolates from these blood samples were verified
for the real-time PCR target and all the S. Typhi and the S.
Paratyphi A strains isolated from the corresponding
blood samples had the appropriate DNA targets.
The real-time PCR was performed on DNA extracted
from blood taken for microbiological culture at the time
of clinical diagnosis, prior to the administration of anti-
microbials. All samples were inoculated with E. coli VU1
before DNA extraction to ensure reliable DNA isolation
and amplification. PCR was performed using 5 μl of DNA
taken from a 300 μl re-suspension volume, which corre-
lated with a 4 ml of whole blood; we calculated that the
final PCR amplification was performed on an equivalent
volume of 75 μl of whole blood. Data resulting from the
positive amplicons is shown in Figure 1.
Reliable amplification was obtained from the E. coli
VU1 internal control strain in all 100 tested samples and
no samples produced an amplicon which indicated co-
infection with both S. Typhi and S. Paratyphi A. Serovar
specific amplification for S. Typhi and for S. Paratyphi A
was observed in 23 and 18 samples respectively. The mul-
tiplex real-time PCR assay, consequently, had a sensitivity
of 42% (23/54) for S. Typhi and 39% (18/46) for S. Para-
typhi A. We were unable to amplify S. Typhi or S. Para-
typhi A target DNA from any of the 50 blood samples
from enteric fever patients that were culture negative, or
from DNA extracted from blood taken from 25 patients
with other known causes of bacteraemia; specificity 100%
(75/75).
The assay was also performed on DNA extracted from
28 bone marrow biopsies which had been cultured and
were known to be positive for S. Typhi. Specific amplifi-
cation of the S. Typhi target sequence was detected in
DNA extracted from all 28 biopsies, thus giving a sensi-
tivity of 100% (28/28) in these specimens (Figure 1).
Quantitative assessment of the resulting Ct  values
s howed t ha t  t he n um be r  of  c o pies o f  tar g et  DNA was
lowest for S. Paratyphi A, ranging from 5 to 2,000 with a
median of 39 copies per ml of blood (Figure 1). The S.
Typhi positive amplifications ranged from 8 to 6,000 cop-
ies per ml, with a median of 60 copies per ml of whole
blood. There was a statistically significant increase (none-
parametric student's t-test) in target copies per ml in
bone marrow samples when compared to blood samples
(Figure 1). The number of S. Typhi target sequence in
bone marrow ranged from 6 to 10,000 with a median of
633 copies per ml.
Real-time PCR detection limit
We demonstrated that an equivalent Ct value could be
generated on DNA extracted from bacteria in PBS and
whole blood, thus inhibition was not the limiting factor in
poor sensitivity on blood specimens. Our data suggested
that the lack of positive PCR amplification was due to the
low number of organisms in the blood sample, which
were below the detection limit of the PCR assay. We com-
pared blood culturing and PCR under experimental con-
ditions. A known quantity of colony forming units of S.
Typhi were inoculated into whole blood. The sample wasNga et al. BMC Infectious Diseases 2010, 10:125
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equilibrated and 10 fold serial dilutions were performed
in whole blood. The diluted blood samples were cultured
in order to enumerate organisms, inoculated into
BACTEC bottles and incubated. Additionally, total DNA
was extracted from all samples and real-time PCR was
performed as before. To assess the effect of antimicrobi-
als (PCR may detect dead organisms) we also performed
an matching experiment, yet the inoculated blood sam-
ples were exposed to gentamicin or ciprofloxacin for 2
hours. Results are presented in Table 4.
Target DNA was consistently amplified in samples up
to the sixth 10 fold dilution, which corresponded to 2.5 ×
102 DNA copies per ml of blood (Table 4). Amplification
was not prevented when samples were treated with anti-
microbials. Culturing of the inoculated blood samples in
BACTEC bottles was consistently more sensitive than
PCR amplification, both in the presence or absence of
antimicrobials (Table 4).
Discussion
A molecular method for the detection of invasive Salmo-
nella serovars in biological specimens appears to be an
attractive addition to current methods. However, PCR is
not commonly reported for the routine identification of
invasive Salmonellae, this is in spite of a number of publi-
cations demonstrating its potential use in the clinical set-
ting for diagnostic testing and bacterial identification
[12,21-23]. It is assumed that PCR amplification may be a
suitable test where blood culturing is not routinely per-
formed. A potential advantage of PCR is that if it had a
high level of sensitivity it may be performed on smaller
volumes of blood than required for culture and may have
Table 2: Assessment of the reproducibility of the multiplex real-time PCR assay on diluted plasmid DNA containing cloned 
target sequences
Amplification target Result Target copies
5 × 104 5 × 103 5 × 102 5 × 101 5 × 100
S. Typhi without internal control Ct value* 22.76 25.61 27.92 31.22 -
S. Typhi with internal control Ct value 22.07 25.56 27.76 31.81 -
Intra-assay variation† CV (%) 0.45 0.25 0.41 0.67 1.01
Inter-assay variation‡ CV (%) 1.86 1 1.97 3.39 1.19
S. Paratyphi A without internal control Ct value 21.27 24.78 27.77 31.16 -
S. Paratyphi A with internal control Ct value 21.42 24.66 28.28 31.84 -
Intra-assay variation CV (%) 0.41 0.7 0.67 0.86 1.34
Inter-assay variation CV (%) 1.34 1.34 0.86 1.25 1.83
* Mean Ct value calculated from 4 individual replicates on 4 separate days, n = 16. †Intra-assay variation was calculated by measuring the co-
efficient of variance of Ct value on 4 concurrently run assays. ‡ Inter-assay variation was calculated by comparing variation in Ct value on 
experiments on 4 individual occasions.
Table 3: Detection limit and Ct value comparison of PCR amplification on nucleic acid extractions from inoculated blood, 
inoculated PBS and purified plasmid DNA
Amplification targets and Ct value
S. Typhi S. Paratyphi A
Equivalent 
cfu/ml
PBS Blood Plasmid PBS Blood Plasmid
1 × 103 Ct value 21.27 24.78 27.77 31.16 -
1 × 104 Ct value 21.42 24.66 28.28 31.84 -
1 × 104 CV (%) 0.41 0.7 0.67 0.86 1.34
1 × 106 C V  ( % ) 1 . 3 41 . 3 40 . 8 61 . 2 51 . 8 3Nga et al. BMC Infectious Diseases 2010, 10:125
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the added ability of detecting dead organisms. Such per-
mutations may be probable in an endemic setting when
taking blood from young children and when patients have
access to none-prescribed antimicrobials.
Many of the previously published S. Typhi nucleic acid
detection studies harbour limitations; the methodology is
often inappropriately validated, equivalent blood volumes
are not specified, the primers are nested and target the
flagellin (fliC) gene and detection is via conventional aga-
rose gel electrophoresis [13,15]. All these limitations may
cause results with may not be reproducible and hinder
the accurate amplification of target sequences in biologi-
cal samples. Furthermore, many such reports suggest the
usefulness of the technique in patients where enteric
fever cannot be confirmed by other methods. Whilst the
rapid nature of a PCR assay may compensate for many
potential limitations, a balanced assessment of PCR sen-
sitivity in a clinical setting was required. Real-time PCR
addresses many of the limitations that can occur with
conventional PCR. The system is sensitive, stringent and
less prone to contamination with DNA from other organ-
isms.
The data presented here may also have some limita-
tions, including, the volume of nucleic acid used in the
experimental procedure, the blood samples originating
from one location and a period of storage prior to DNA
Figure 1 Real-time PCR amplification of S. Typhi and S. Paratyphi A in blood and bone marrow specimens from patients with culture con-
firmed enteric fever. The Ct values of amplification positive blood and bone marrow specimens have been converted by dilution factor to copies 
per ml of biological material (y axis). The median and quartile ranges of the number of copies per ml of biological sample are shown for amplification 
positive blood samples with S. Paratyphi A (n = 18), amplification positive blood samples with S. Typhi (n = 23) and amplification positive bone marrow 
samples with S. Typhi (n = 28). Statistical significance was calculated using a none-parametric student's t-test.Nga et al. BMC Infectious Diseases 2010, 10:125
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extraction. Nonetheless, this work represents an unbi-
ased assessment of PCR in the identification of S. Typhi
and S. Paratyphi A in biological specimens. The blood
inoculation and bacterial quantification experiments sup-
port our findings on biological specimens and address
some of the limitations from biological samples.
We attribute a lack of sensitivity of the assay to the low
physiological level of invasive Salmonella organisms in
the blood. The detection limits of the real-time PCR were
c o m p a r a b l e  w i t h  c f u / m l  i n  b o t h  i n o c u l a t e d  b l o o d  a n d
saline samples, demonstrating that human DNA or
potential PCR inhibitors found in blood may not hinder
amplification. We additionally found that a realistic
detection limit of the assay was between 100 to 200
organisms per ml of whole blood. This may be increased
by extracting DNA from a greater blood volume or by
precipitation of the extracted DNA. Both improvements
would be technically challenging and even if these limita-
tions are taken into account, PCR may still fail to reach
the sensitivity level of a standard blood culture.
Our quantitative data demonstrated median copies of
target sequence of 39 and 60 per ml of blood for S. Para-
typhi A and S. Typhi respectively and 600 copies of S.
Typhi target per ml of bone marrow. These data are
somewhat incomparable with a previous real-time PCR
detection assay for S.  Typhi in peripheral blood [10].
Massi  et al. found a statistically significant difference
between hypothetical loads of bacteria in blood between
culture negative and culture positive blood specimens.
Patients that were culture positive had between 1,010 and
4,350 target copies per ml of blood, whereas, patients that
were culture negative had between 3.9 and 990 copies per
ml of blood. Even taking into account dead organisms,
these figures correspond with substantial bacterial loads
in the blood of enteric fever patients. This discrepancy is
an important observation as it has been shown that S.
Typhi induces febrile disease with a nominal number of
organisms circulating in the blood. Using quantitative
counts of bacteria in blood, Wain et al. demonstrated that
25% of all acute typhoid patients had less than 0.1 cfu/ml
and only 1% tested had a cfu/ml of greater than 100
organisms per ml of blood [24]. Our PCR results concur
with these data and supports our understanding that the
lack of sensitivity is dependent on the low number of
invasive Salmonellae in the blood. Therefore, to detect a
living organism, the PCR would have to be performed
directly on DNA extracted from 10 ml of blood. A lack of
detectable organisms is a potential consideration for
other bacterial pathogens, such as Mycobacterium tuber-
culosis; meta-analyses suggest that PCR detection of this
organism in biological material may also pose a similar
challenge [25,26].
It is of note, however, that the PCR assay demonstrated
a sensitivity of 100% on culture positive bone marrow
biopsies. Bacterial loads in bone marrow biopsies from
enteric fever patients have been shown to be significantly
higher than bacterial loads in peripheral blood [16].
Additionally, the tenfold increase in copies per ml in bone
marrow, when compared to blood, may be explained not
only by the organisms surviving within macrophages in
the bone marrow, but also the potential ability of the
assay to detect DNA from dead organisms within cells. A
combination of culturing, either from blood or bone mar-
row, with PCR amplification may improve sensitivity and
time to diagnosis. It is clear that typhoid diagnostics
requires the use of some new approaches and fresh con-
siderations [27].
Conclusions
Our data demonstrates that a low level of bacteria in the
blood makes PCR amplification of specific S. Typhi and S.
Paratyphi A sequences on biological samples technically
challenging. Whilst specificity for the technique is indis-
putably high, the sensitivity when compared to blood cul-
turing is low. Further assessment of the use of PCR
amplification for the detection of invasive Salmonellae in
blood is required. Previous publications have demon-
strated that PCR is both a specific and highly sensitive
method for detection of S. Typhi in blood. Our study
questions the use of PCR for the diagnosis of enteric fever
Table 4: Comparison of real-time PCR detection to blood culture with known inoculants of S. Typhi into blood samples
Experimental condition and detection method
No antimicrobial Gentamicin Ciprofloxacin
Dilution 
factor
cfu/ml Ct value Blood 
culture
cfu/ml Ct value Blood 
culture
cfu/ml Ct value Blood 
culture
10-4 2.5 × 104 30.18 + 1 × 104 30.44 + 3 × 103 30.31 +
10-5 2.5 × 103 33.53 + 1 × 103 33.45 + 3 × 102 33.44 +
10-6 2.5 × 102 37.77 + 1 × 102 37.07 + 3 × 101 36.95 +
10-7 2.5 × 101 - + 1 × 101 - + 3 × 100 -+
10-8 <2.5 × 101 - + <1 × 101 - + <3 × 103 --Nga et al. BMC Infectious Diseases 2010, 10:125
http://www.biomedcentral.com/1471-2334/10/125
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and suggests that the number of organisms and the vol-
ume of blood required for accurate identification using
PCR on biological samples may be un-physiological and
impractical.
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